Recent News

Stay up to date with the latest news from Neurent Medical

Neurent Medical Announces New CPT Code® for Chronic Rhinitis Treatment Offering Significant Symptom Improvements

13th November 2023


New Data show NEUROMARK® Chronic Rhinitis Treatment Offers Significant Symptom Improvements

21st March 2023

Significant Symptom Improvements

Neurent Medical Announces Limited Market Release of NEUROMARK® System to Treat Chronic Rhinitis

3rd February 2023

Press release about Limited Release

Neurent Medical Receives FDA Clearance for NEUROMARK, a Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis

18th November 2021

Press release about FDA Clearance

Neurent Medical Expands Leadership Team to Support Advancement of In-Office Chronic Rhinitis Treatment

24th June 2021

Press release about Leadership Team expansion

Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment

20th January 2021

Press release about the $25 Million Series B Funding.

Neurent Medical raises €9.3m.

28th May 2018

A write up in the Irish Times.

Irish Medtech Awards finalists revealed.

2nd Nov 2018

Article on

Frost & Sullivan recognises Neurent Medical.

13th Nov 2018

Article on Cision.